Rakovina Therapeutics Inc (TSE:RKV) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Rakovina Therapeutics Inc. announced its participation in the 13th Annual Tumour Models London Summit, where it will showcase its innovative cancer treatment research. Prof. Mads Daugaard, the company’s president, will present the development of 3D bioprinted bone mimics for drug screening and cancer research. The summit is a platform for sharing advanced insights into drug discovery and cancer therapy.
For further insights into TSE:RKV stock, check out TipRanks’ Stock Analysis page.